Commentary - (2024) Volume 12, Issue 1
Received: 28-Jan-2024, Manuscript No. JPGEB-24-129381;
Editor assigned: 31-Jan-2024, Pre QC No. P-129381;
Reviewed: 14-Feb-2024, QC No. Q-129381;
Revised: 19-Feb-2024, Manuscript No. R-129381;
Published:
20-Feb-2024
, DOI: 10.37421/2329-9002.2024.12.298
Citation: Berrebi, Peter. “Understanding Leishmania donovani’s
Non-vesicular Lipid Transport Mechanisms: Implications for Host-parasite
Interaction.” J Phylogenetics Evol Biol 12 (2024): 298.
Copyright: © 2024 Berrebi P. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Leishmania donovani, a protozoan parasite transmitted by the bite of infected sandflies, is the causative agent of visceral leishmaniasis, a potentially fatal disease affecting millions worldwide. The intricate interplay between the parasite and its host involves various molecular mechanisms, including lipid transport. While vesicular lipid transport mechanisms in Leishmania have been extensively studied, non-vesicular lipid transport mechanisms have gained attention recently due to their potential implications in host-parasite interactions. In this article, we delve into the non-vesicular lipid transport mechanisms in Leishmania donovani and their functional consequences for host-parasite interaction [1].
Leishmania donovani exhibits several non-vesicular lipid transport mechanisms, primarily mediated by lipid-binding proteins and lipid transfer proteins. These proteins facilitate the intracellular trafficking of lipids without the involvement of membrane-bound vesicles. Leishmania donovani encodes various lipid-binding proteins such as fatty acid-binding proteins and sterol carrier proteins. These proteins have high affinity for specific lipid molecules and play crucial roles in lipid uptake, storage, and metabolism within the parasite. FABPs in Leishmania are involved in the transport of fatty acids across cellular compartments [2].
They bind to long-chain fatty acids and facilitate their transport to various organelles, including the glycosome and mitochondria, where they serve as energy sources and participate in lipid biosynthesis. SCPs are responsible for the intracellular transport of sterols, essential components of the parasite's cell membrane. By shuttling sterols between organelles, SCPs regulate membrane fluidity and integrity, thus influencing the infectivity and survival of Leishmania within the host. Besides lipid-binding proteins, Leishmania donovani also employs lipid transfer proteins to facilitate the inter-organelle transfer of lipids. LTPs interact with membranes and mediate the direct transfer of lipids between membranes without the formation of vesicles. LTPs play a crucial role in maintaining lipid homeostasis and membrane composition in Leishmania. They facilitate the redistribution of lipids between different organelles, ensuring the availability of lipids for various metabolic processes essential for parasite survival and virulence [3].
Moreover, LTP-mediated lipid transfer may contribute to the evasion of host immune responses by modulating the lipid composition of parasite membranes, thereby altering their recognition by host immune cells. Lipid transport mechanisms enable Leishmania to scavenge and utilize host lipids for energy production and biosynthetic processes. By efficiently acquiring and metabolizing host lipids, the parasite can adapt to diverse host environments and sustain its intracellular growth and proliferation. Manipulation of host lipid metabolism by Leishmania may also contribute to disease pathogenesis by altering the host's lipid profile and metabolic pathways, leading to immunomodulation and tissue damage [4].
Non-vesicular lipid transport mechanisms play a crucial role in modulating the lipid composition of parasite membranes, influencing their recognition by host immune cells and evasion of host immune responses. By altering the lipid profile of their membranes, Leishmania can evade phagocytosis and intracellular killing by host macrophages, promoting their survival and dissemination within the host. Additionally, lipid-mediated signaling pathways may regulate the expression of virulence factors and immune evasion strategies in Leishmania, enhancing its infectivity and pathogenicity. The lipid transport machinery of Leishmania donovani may contribute to drug resistance by facilitating the efflux of toxic lipids or drugs from intracellular compartments, reducing their accumulation and efficacy against the parasite. Understanding the mechanisms underlying lipid transport in Leishmania is crucial for the development of novel therapeutic strategies targeting lipid metabolism and transport pathways to overcome drug resistance and improve treatment outcomes [5].
Non-vesicular lipid transport mechanisms play a vital role in the biology of Leishmania donovani and have significant implications for host-parasite interaction, disease pathogenesis, and drug resistance. Elucidating the molecular mechanisms underlying lipid transport in Leishmania is essential for deciphering the complex interplay between the parasite and its host and developing effective interventions to combat visceral leishmaniasis. Further research into the regulation and functional consequences of non-vesicular lipid transport pathways in Leishmania will provide valuable insights into parasite biology and potential targets for therapeutic intervention.
Not applicable.
There is no conflict of interest by author.
Google Scholar, Crossref, Indexed at
Google Scholar, Crossref, Indexed at
Google Scholar, Crossref, Indexed at
Google Scholar, Crossref, Indexed at
Journal of Phylogenetics & Evolutionary Biology received 911 citations as per Google Scholar report